Anti-NY ESO-1 mTCR Peripheral Blood Lymphocytes

Stopped Due to lack of accrual the study was formally terminated on 01-JUL-2020. Primary Completion and Study Completion Dates have been revised based accordingly based on respective definitions

Conditions

• HLA-A2 Positive Cells Present
• Metastatic Malignant Neoplasm
• Metastatic Malignant Neoplasm in the Brain

Interventions

• BIOLOGICAL: Aldesleukin
• BIOLOGICAL: Anti-thyroglobulin mTCR-transduced Autologous Peripheral Blood Lymphocytes
• DRUG: Cyclophosphamide
• BIOLOGICAL: Filgrastim
• DRUG: Fludarabine Phosphate
• OTHER: Laboratory Biomarker Analysis

Sponsor

Albert Einstein College of Medicine

Collaborators

• [object Object]